This HTML5 document contains 196 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
n5http://dx.doi.org/10.1007/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n12https://scigraph.springernature.com/pub.10.1007/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q36649356
rdf:type
wikibase:Item
schema:description
artigo científico wetenschappelijk artikel наукова стаття, опублікована в лютому 2013 scienca artikolo 2013年論文 2013년 논문 scientific article published on 19 February 2013 vědecký článek bilimsel makale vitenskapelig artikkel บทความทางวิทยาศาสตร์ 2013 nî lūn-bûn artigo científico scientific article published on 19 February 2013 2013年論文 vitskapeleg artikkel 2013年论文 artikull shkencor article científic artículo científico publicado en 2013 article scientifique מאמר מדעי 2013年论文 tudományos cikk научная статья επιστημονικό άρθρο vedecký článok articolo scientifico 2013年論文 2013年论文 мақолаи илмӣ articol științific wissenschaftlicher Artikel scientific article published on 19 February 2013 2013年论文 ১৯ ফেব্রুয়ারি ২০১৩-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ مقالة علمية نشرت في 19 فبراير 2013 2013年の論文 artikulong pang-agham artigo científico naučni članak article scientific artikel ilmiah სამეცნიერო სტატია artículu científicu espublizáu en 2013 2013年論文 2013年論文 bài báo khoa học vetenskaplig artikel artykuł naukowy teaduslik artikkel 2013年论文 2013年论文 научни чланак tieteellinen artikkeli научна статия научни чланак videnskabelig artikel
p:P577
wds:Q36649356-FC77CC4B-993B-475D-8AD5-5DC46BDAE02F
wdt:P577
2013-02-19T00:00:00Z
p:P407
wds:Q36649356-102A5A49-4485-4D46-B448-D0130E987D3C
wdt:P407
wd:Q1860
p:P2888
wds:Q36649356-92D35320-9444-4336-A978-077013491BA0
wdt:P2888
n12:s10549-013-2444-y
p:P2860
wds:Q36649356-0A1DCF41-3807-4D14-B92C-EB27E96214F2 wds:Q36649356-AB23141C-1E15-46E9-AEAA-C12DB5F4C09E wds:Q36649356-B17CDC2A-DB70-406D-937E-39BBDAF86673 wds:Q36649356-B3966B18-8C3A-4F7F-9F30-EB4F11FA9C2D wds:Q36649356-B6C63F1E-4361-4D68-A64B-2216814DCBEC wds:Q36649356-BE94B88E-30A1-416F-8254-9F6602C6CB3F wds:Q36649356-BF5AF404-9B57-446C-B2A9-887D209C9596 wds:Q36649356-C09E6BB4-FF57-4FB5-834B-2BF00CEC4798 wds:Q36649356-C11F97EC-9897-4179-BE26-9AE4DAF7DAAD wds:Q36649356-C66502BE-4DE0-40CD-A7BD-5EE3134A8558 wds:Q36649356-D35A1820-DB68-46AA-8281-9270EA047270 wds:Q36649356-F3430E9E-BBCA-40D2-AC11-71A6960FCBEF wds:Q36649356-FFC4ADFB-6291-4D80-A3A9-AA4A6F28E65F wds:Q36649356-10CECEBF-F21B-4DE4-B712-09C1C259C817 wds:Q36649356-14640011-AEF0-46AD-9547-4B5F8FEE1E40 wds:Q36649356-17919552-FD81-40B9-9FA7-F73EDE3CD664 wds:Q36649356-200FF9C5-0D2D-4469-BEFF-8BD1E919189C wds:Q36649356-234B22CC-2AAF-4191-A5F3-EFC7C55C29DA wds:Q36649356-253FA0A0-BEA6-4C28-9871-43C0640BE170 wds:Q36649356-3B02E4DF-ECCD-408C-BFBE-82E34E4D4331 wds:Q36649356-3ECF3EC8-1DAC-422B-ADD4-790BCB25275C wds:Q36649356-4781CAE4-156C-462A-92DC-964675E2386E wds:Q36649356-5A537803-63AE-4920-9181-8DA4F3504D4A wds:Q36649356-5E8CDB0C-51E3-40F7-8AC9-28F9C5E46595 wds:Q36649356-66B5EB0B-C453-49A8-84F6-06393B574BC3 wds:Q36649356-6B0F54FD-3749-431D-8022-14220968177C wds:Q36649356-75D7F17E-6EF4-464C-AB55-077E591DE13B wds:Q36649356-8D007EE1-2C36-454B-9270-7466F57F1D05 wds:Q36649356-91194FED-A9CC-4C5C-9EAB-8AAA671F1D41
wdt:P2860
wd:Q79816337 wd:Q79825280 wd:Q48001325 wd:Q34194672 wd:Q45946352 wd:Q37426293 wd:Q53593820 wd:Q83722585 wd:Q34424285 wd:Q27860693 wd:Q37388937 wd:Q37816060 wd:Q34071408 wd:Q33504464 wd:Q84706267 wd:Q37776218 wd:Q34451337 wd:Q51918651 wd:Q54660266 wd:Q35710898 wd:Q38474138 wd:Q36678853 wd:Q42942117 wd:Q53664980 wd:Q80959592 wd:Q46037818 wd:Q81151636 wd:Q29547699 wd:Q33397151
p:P2093
wds:Q36649356-F90C144D-A09A-41CD-946A-ACD463D6F078 wds:Q36649356-96ABEC6D-6CB9-4BBB-BBFA-B1F28A55BB8D wds:Q36649356-C57E2121-0256-45FB-8D4E-46A13A5863A2 wds:Q36649356-C15FC04D-8923-4167-89A0-FED739CAAC58 wds:Q36649356-0525E32D-38C6-4798-BA4E-AF63C2876339 wds:Q36649356-070C8DE7-16EE-4B89-86AE-D55E8D2FBDB9 wds:Q36649356-03925B05-BD60-47FA-8F40-1D520521C962 wds:Q36649356-657AEC92-3A5C-47CE-887F-1EFF69E35032 wds:Q36649356-4700AEA4-FCA7-4566-BBE4-050DD423E18C wds:Q36649356-917560FE-A801-4A38-8860-AAB82CB626FA wds:Q36649356-7A02048F-0934-454D-9185-FE4B54A191F0 wds:Q36649356-23BE3618-38E1-4723-A189-D0F2601DC4B4 wds:Q36649356-3682E343-0C08-4CFE-80AE-00F04BCC1355 wds:Q36649356-31BF429F-8F73-49B1-AE0F-9A5B1989AC0B
wdt:P2093
Dennis J Slamon Soonmyung Paik Melanie Finnigan Mona Shing Reid Meyer Robert B Jenkins Beiyun Chen Michael F Press Ivonne Villalobos Joanne Zujewski Anne E Wiktor Monica M Reinholz Howard M Stern Marc Buyse
rdfs:label
Immunohistochemistry and fluorescence in situ hybridization assessment of HER2 in clinical trials of adjuvant therapy for breast cancer (NCCTG N9831, BCIRG 006, and BCIRG 005). Immunohistochemistry and fluorescence in situ hybridization assessment of HER2 in clinical trials of adjuvant therapy for breast cancer (NCCTG N9831, BCIRG 006, and BCIRG 005). Immunohistochemistry and fluorescence in situ hybridization assessment of HER2 in clinical trials of adjuvant therapy for breast cancer (NCCTG N9831, BCIRG 006, and BCIRG 005).
skos:prefLabel
Immunohistochemistry and fluorescence in situ hybridization assessment of HER2 in clinical trials of adjuvant therapy for breast cancer (NCCTG N9831, BCIRG 006, and BCIRG 005). Immunohistochemistry and fluorescence in situ hybridization assessment of HER2 in clinical trials of adjuvant therapy for breast cancer (NCCTG N9831, BCIRG 006, and BCIRG 005). Immunohistochemistry and fluorescence in situ hybridization assessment of HER2 in clinical trials of adjuvant therapy for breast cancer (NCCTG N9831, BCIRG 006, and BCIRG 005).
schema:name
Immunohistochemistry and fluorescence in situ hybridization assessment of HER2 in clinical trials of adjuvant therapy for breast cancer (NCCTG N9831, BCIRG 006, and BCIRG 005). Immunohistochemistry and fluorescence in situ hybridization assessment of HER2 in clinical trials of adjuvant therapy for breast cancer (NCCTG N9831, BCIRG 006, and BCIRG 005). Immunohistochemistry and fluorescence in situ hybridization assessment of HER2 in clinical trials of adjuvant therapy for breast cancer (NCCTG N9831, BCIRG 006, and BCIRG 005).
p:P50
wds:Q36649356-4FED3137-E474-4A1F-B7A0-5993B375C904 wds:Q36649356-2686C98D-BC2E-42A9-8815-9D9E1A371FE1 wds:Q36649356-0E555DEF-68FB-4B15-8208-E5364EA96E31 wds:Q36649356-00808763-B275-4E0C-A00F-B12C7FCF2EB6
wdt:P50
wd:Q18389345 wd:Q57010680 wd:Q79379347 wd:Q112850014
p:P1476
wds:Q36649356-AAB26588-6443-4EF2-AEA3-4FC4E17F1785
wdt:P1476
Immunohistochemistry and fluorescence in situ hybridization assessment of HER2 in clinical trials of adjuvant therapy for breast cancer (NCCTG N9831, BCIRG 006, and BCIRG 005)
p:P304
wds:Q36649356-73703CBF-458A-4302-9572-234614932DFB
wdt:P304
99-108
p:P31
wds:Q36649356-0EC95E1D-DAFD-4F08-9DD6-AED9F737561B
wdt:P31
wd:Q13442814
p:P921
wds:Q36649356-245A6745-DED8-451E-B1CA-FC347925D7FD
wdt:P921
wd:Q899285
p:P698
wds:Q36649356-A0642A1D-1D5A-4878-A1C1-4CA36399445D
wdtn:P698
n11:23420271
wdt:P698
23420271
p:P1433
wds:Q36649356-9903AD84-0548-4175-B181-7C7316B2F549
wdt:P1433
wd:Q326085
p:P433
wds:Q36649356-E0609049-4FC3-4C85-B69E-BB51EEF4F550
p:P478
wds:Q36649356-2F47D602-B823-4BA1-950D-C46C35669C2C
wdt:P433
1
wdt:P478
138
p:P356
wds:Q36649356-A3CDC035-C929-4977-BA4C-A76DBB032252
wdtn:P356
n5:S10549-013-2444-Y
wdt:P356
10.1007/S10549-013-2444-Y
p:P275
wds:Q36649356-b7630406-96e9-4e0d-aa41-14b429b713ba
p:P6216
wds:Q36649356-42cd7bdb-72a6-4354-be1e-6285b0b227af
wdt:P275
wd:Q19113746
wdt:P6216
wd:Q50423863
p:P5875
wds:Q36649356-7E6CEBC4-F511-4C93-993F-3E6A40F86D03
wdt:P5875
235658892
p:P932
wds:Q36649356-196F8348-62C8-481F-8F3D-BCF841636AE3
wdt:P932
3585916